Publications by authors named "Edward Neuberger"

Claim this Profile
T
The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancer.
Karen Bartley, Jeremy Snider, Cheryl Cho-Phan, Jingru Wang, Peter Martin, Edward Neuberger

Future Sci OA· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases.
Carey Anders, Edward Neuberger, Naomi R M Schwartz, Karen Bartley, Shu Wang

Int J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Outcomes in Patients With HER2+ Metastatic Breast Cancer Receiving Tucatinib-Based Therapy After 2 or More Prior Metastatic HER2-Directed Regimens.
Carey Anders, Edward Neuberger, Karen Bartley, Brian T Pittner, Amadou Sow

Cancer Control· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer.
Peter A Kaufman, Edward Neuberger, Naomi R M Schwartz, Shu Wang, Yutong Liu

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Use and Health Care Use Among US Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016-2019.
Edward E Neuberger, Tu My To, Arpamas Seetasith, Stella M Arndorfer, Chris J Wallick

ACR Open Rheumatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baloxavir vs oseltamivir: reduced utilization and costs in influenza.
Edward Neuberger, Chris Wallick, Devika Chawla, Rita de Cassia Castro

Am J Manag Care· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis.
Edward E Neuberger, Ibrahim M Abbass, Eddie Jones, Natalie J Engmann

Neurol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".
Edward E Neuberger, Josh J Carlson, David L Veenstra

Pharmacoeconomics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome.
Edward E Neuberger, Josh J Carlson, David L Veenstra

Pharmacoeconomics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Value of Pharmacogenetic Testing for Cancer Drugs with Clinically Relevant Drug-Gene Associations: A Systematic Literature Review.
Fahim Faruque, Heejung Noh, Arif Hussain, Edward Neuberger, Eberechukwu Onukwugha

J Manag Care Spec Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis